Syndax Pharmaceuticals In...

NASDAQ: SNDX · Real-Time Price · USD
15.71
0.98 (6.65%)
At close: Aug 15, 2025, 3:59 PM
16.00
1.88%
After-hours: Aug 15, 2025, 07:56 PM EDT

Syndax Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-71.85M -84.85M -94.17M -84.13M -68.06M -72.4M -72.47M -51.15M -44.62M -41.13M -39.19M -35.4M -37.57M -37.17M 96.2M -20.64M -22.91M -27.72M
Depreciation & Amortization
55K 112K n/a 2K 3K 3K 3K 3K 3K 3K 3K 8K 11K 11K 10K 8K 9K 16K
Stock-Based Compensation
13.79M 10.38M 12.3M 11.93M 9.9M 8.9M 8.33M 8.32M 8.06M 6.24M 4.24M 4.36M 3.94M 3.48M 3.93M 3.38M 3.24M 2.77M
Other Working Capital
n/a -3.58M 26.46M 10.82M -4.88M -9.56M 22.1M 6.52M 1.82M -4.19M 16.73M 1.96M -4.88M -10.84M 715K -9.59M -1.88M -998K
Other Non-Cash Items
-29.79M -20.81M -2.7M -2.76M 11.69M 12.24M -10.59M 237K 149K -3.86M -1.91M -145K 258K 22K -472K 228K 216K 215K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 7.38M -3.66M -3.72M n/a n/a n/a n/a n/a -218K 173K 187K 113K
Change in Working Capital
n/a n/a 27.19M 12.63M -10.07M -16.47M 26.01M 1.59M 4.75M -486K 13.97M 2.63M -6.67M -8.27M 1.26M -8.1M -4.79M 2.02M
Operating Cash Flow
-87.8M -95.16M -57.39M -62.32M -71.64M -83.55M -41.35M -44.65M -35.37M -39.23M -22.89M -28.54M -40.31M -41.93M 100.71M -24.94M -24.05M -22.59M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -225K n/a n/a -129K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 225K n/a n/a n/a n/a n/a n/a
Purchase of Investments
-91.71M -10.54M -376.31M -13.35M n/a -167.38M -129.29M -82.72M -81.01M -61.59M -250.88M -79.83M -122.37M -42.27M -105.23M -62.94M -59.82M -66.73M
Sales Maturities Of Investments
133.6M 104.68M 107.34M 100.2M 61.75M 67.99M 113M 122.8M 154.91M 81.5M 113.25M 72.82M 72.42M 50.45M 45.4M 89.58M 81.5M 37.5M
Other Investing Acitivies
n/a n/a n/a n/a 61.75M -99.4M -16.29M 40.08M 73.91M 19.91M -137.63M 225K -49.95M 8.18M -59.83M 26.63M 21.68M -29.23M
Investing Cash Flow
41.89M 94.14M -268.97M 86.85M 61.75M -99.4M -16.29M 40.08M 73.91M 19.91M -137.63M -6.79M -49.95M 8.18M -59.96M 26.63M 21.68M -29.23M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2K n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
551K 930K 347.43M 3.1M 676K 2.17M 389K 1.85M 1.32M 2.47M 1.14M -13.53M 21.72M 557K 28.57M 1.71M 889K 960K
Financial Cash Flow
551K 930K 347.43M 3.1M 676K 2.17M 258.48M 1.85M 1.32M 2.47M 163.5M -13.53M 21.72M 557K 109.78M 1.71M 6.02M 960K
Net Cash Flow
-45.36M -90K 21.06M 27.84M -9.22M -180.78M 200.84M -2.73M 39.86M -16.84M 2.98M -48.86M -68.53M -33.19M 150.53M 3.39M 3.65M -50.86M
Free Cash Flow
-87.8M -95.16M -57.39M -62.32M -71.64M -83.55M -41.35M -44.65M -35.37M -39.23M -22.89M -28.77M -40.31M -41.93M 100.58M -24.94M -24.05M -22.59M